头颈癌根治性放化疗后管饲依赖的预后因素系统综述
结论认为DVH参数(喉、咽缩肌、对侧腮腺剂量)、晚期肿瘤分期、疗前体重下降、同步化疗和预防性胃造瘘政策与≥6个月管饲依赖相关。
要点
- ≥6个月管饲依赖的预后因素包括喉、咽缩肌和对侧腮腺剂量等DVH参数。
- 晚期肿瘤分期、疗前体重下降、同步化疗和预防性胃造瘘政策亦与≥6个月管饲依赖相关。
- <6个月管饲使用相关DVH参数包括口腔黏膜剂量与体积、对侧颌下腺、喉和咽缩肌剂量。
核心结论
- ≥6个月管饲依赖的预后因素包括喉、咽下缩肌和咽上缩肌剂量及对侧腮腺剂量等DVH参数。
- 晚期肿瘤和淋巴结分期、疗前体重下降、同步化疗和预防性胃造瘘政策也是≥6个月管饲依赖的预后因素。
- <6个月管饲使用的预后DVH参数包括口腔黏膜剂量和体积、对侧颌下腺剂量以及喉和咽下缩肌、咽上缩肌剂量。
研究设计与样本
- 该系统综述按PRISMA指南开展,检索MEDLINE、EMBASE和Cochrane Library,筛选约2600篇文章。
主要发现
- 其中2项研究报告了管饲依赖模型,1项模型纳入了DVH参数。
- 18项研究报告了<6个月管饲放置和使用的预后因素。
关键数值与推荐
- ≥6个月管饲依赖的一致预后因素为DVH参数:喉剂量、咽下缩肌和咽上缩肌剂量、对侧腮腺剂量。
- ≥6个月管饲依赖的其他预后因素为晚期肿瘤和淋巴结分期、疗前体重下降、同步化疗和预防性胃造瘘政策。
- <6个月管饲使用的预后DVH参数包括口腔黏膜剂量和体积、对侧颌下腺剂量、喉和咽下缩肌及咽上缩肌剂量。
- <6个月管饲放置和使用的患者/疾病及治疗预后因素与≥6个月管饲依赖因素相似,还包括疗前使用麻醉药和独居等独特变量。
临床怎么用
- 可基于喉、咽缩肌和对侧腮腺剂量等DVH参数优化放疗计划以降低管饲依赖风险。
- 对晚期肿瘤分期、疗前体重下降、接受同步化疗或所在机构采用预防性胃造瘘政策的患者应加强管饲风险预警。
局限性
- 仅2项研究报告了管饲依赖模型,其中仅1项纳入DVH参数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tube feeding dependence is a commonly observed debilitating side-effect of curative (chemo-) radiation in head and neck cancer patients that severely affects quality of life. Prevention of this side-effect can be obtained using advanced radiation techniques, such as IMRT. For radiotherapy treatment plan optimization, it has become increasingly important to develop prediction models that enable clinicians to predict the risk of tube feeding dependence for individual patients. To develop such a tool, information regarding the most relevant prognostic factors for tube feeding dependence is necessary. OBJECTIVES: The primary aim of this systematic review, conducted according to PRISMA guidelines, was to identify prognostic factors that are consistently found to be associated with tube feeding dependence at ≥6months after treatment. The secondary aim was to identify prognostic factors found to be associated with tube feeding placement and use at <6months. DATA SOURCES: Articles were identified through a search in MEDLINE, EMBASE and the Cochrane Library. Approximately 2600 articles were screened and selected by inclusion and exclusion criteria. RESULTS: Fourteen retrospective studies were identified that fulfilled the inclusion criteria and reported on prognostic factors for tube feeding dependence at ≥6months. The studies reported on patient and disease variables, treatment variables and DVH parameters. Two of these studies reported on a model for tube feeding dependence, one including DVH parameters. Additionally, 18 studies were identified that reported on prognostic factors for tube feeding placement and use at <6months. CONCLUSIONS: Prognostic factors that were consistently associated with the risk of tube feeding dependence at ≥6months for head and neck cancer patients treated with (chemo-) radiotherapy were DVH parameters, including dose to the larynx, the pharyngeal constrictor muscle inferior and superior, and the dose to the contralateral parotid gland. Furthermore, advanced tumor and nodal stage, pretreatment weight loss, (concomitant) chemotherapy and prophylactic gastrostomy policy were prognostic for tube feeding dependence ≥6months. For tube feeding use at less than 6months, prognostic DVH parameters included dose and volume to the oral mucosa, dose to the contralateral submandibular gland, and also dose to the larynx and the pharyngeal constrictor muscle inferior and superior. Prognostic patients/disease and treatment factors for tube feeding placement and use at less than 6months were similar to the prognostic factors for tube feeding dependence at ≥6months, but also included several unique variables such as the use of narcotics prior to treatment and living alone at the time of treatment.
引用
- Wopken K, Bijl HP, Langendijk JA, et al. Prognostic factors for tube feeding dependence after curative (chemo-) radiation in head and neck cancer: A systematic review of literature. Radiother Oncol. 2017. PMID: 28943045. doi:10.1016/j.radonc.2017.08.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。